Accounting for Biomedical Healthcare Startups
Biomedical breakthroughs fail faster when the numbers cannot survive investor, grant, tax, or audit review.
Accounting-biomedical-healthcare-startups is not ordinary bookkeeping. Your accounts need to support R&D tax credit claims, grant reporting, clinical trial cost tracking, licensing revenue, payroll costs, contractor spend, investor packs, and board-level runway decisions. Pearl Lemon Accountants works with biomedical, biotech, medtech, healthtech, diagnostics, and healthcare startups that need financial records built for funding pressure, not just year-end filing.
If your next milestone involves NIH, SBIR, BARDA, FDA-linked spend, ASC 606 revenue, or investor due diligence, your finance setup needs to be clean before questions start.
- Up to $500,000 potential payroll tax credit offset for eligible qualified small businesses
- R&D, clinical, grant, payroll, contractor, and lab costs coded by activity
- ASC 606 support for licensing, royalties, and milestone-based revenue
- Monthly burn rate and runway reports prepared for investor review
Accounting Built Around Biomedical Funding Pressure
Biomedical and healthcare startups do not need vague monthly reports. You need financial records that show where capital went, which costs qualify for relief, whether grant money is properly tracked, how revenue should be recognised, and how long your runway really lasts.
Our accounting services give founders, finance leads, and operators the numbers needed for grant reporting, tax credit support, investor meetings, board packs, and audit preparation.
R&D Tax Credit and Expense Structuring
Biomedical startups spend heavily before commercial revenue arrives. Payroll, supplies, contractors, lab work, prototype testing, preclinical activity, software development, and clinical research may all need clean classification before an R&D tax credit claim can be reviewed.
We help separate qualified research activity from general operating spend, build supporting schedules, check payroll tax credit relevance, and prepare documentation that gives your claim a stronger financial base.
This gives you cleaner R&D records, better tax credit readiness, and fewer problems when your accountant, tax consultant, investor, or reviewer asks for evidence.
- Qualified research expense review
- Payroll, contractor, lab, and supply cost mapping
- R&D cost schedules
- Pre-revenue payroll tax credit support
- Documentation checks before filing
- Clear separation between research and admin costs
Grant Compliance and Clinical Trial Cost Accounting
Grant-funded biomedical startups need more than tidy bookkeeping. NIH, SBIR, BARDA, and other funding programmes often require costs to be tracked against budgets, allowable categories, direct costs, indirect costs, project codes, and reporting periods.
We help set up cost tracking so grant money does not get mixed into general operating spend. That means clearer reporting, stronger audit trails, and fewer last-minute problems when grant updates, renewals, or reviews are due.
Clinical trials add another layer. CRO invoices, investigator payments, patient costs, lab fees, site payments, and trial milestones need to be recorded in the right period so financial statements reflect actual programme activity.
- Grant code setup
- Direct and indirect cost tracking
- Allowable and unallowable cost separation
- CRO invoice coding
- Clinical site payment tracking
- Trial accrual support
- Grant reporting schedules
ASC 606 Revenue Recognition for Licensing and Milestones
Biomedical and healthcare startups often receive income through licensing fees, royalties, collaboration agreements, milestone payments, or commercial partnerships. Recording this income when cash arrives can create misleading financial statements if contract obligations have not been met.
We review revenue streams against ASC 606 principles so your reports better reflect performance obligations, deferred revenue, variable consideration, and milestone timing.
This matters before investor review, audit preparation, board reporting, acquisition talks, and any situation where financial accuracy affects valuation or trust.
- Licensing revenue review
- Milestone payment treatment
- Royalty income tracking
- Deferred revenue checks
- Contract obligation mapping
- Investor-ready revenue schedules
Burn Rate, Runway, and Cash Flow Control
A biomedical founder cannot rely on a basic profit and loss report. You need to know how long cash lasts, which spend is tied to research progress, which costs are fixed, and when the next funding event becomes critical.
We build reporting around burn rate, runway, research milestones, payroll, contractors, grant spend, clinical costs, and operational overhead. This gives leadership a clearer view of when to cut, raise, hire, pause, or move money.
Clean runway reporting also strengthens investor conversations because it shows discipline, not panic.
- Monthly burn rate reporting
- Runway models
- Cash flow planning
- Board-ready financial summaries
- Programme-level spend tracking
- Hiring and payroll cost visibility
- Funding timeline support
Investor-Ready Financial Reporting
Investors do not only assess the science. They assess whether the company can explain its numbers. Weak reporting, missing reconciliations, unclear R&D costs, and inconsistent revenue treatment can slow diligence and damage confidence.
We prepare startup financials so they can stand up to investor review. That includes monthly management accounts, clean reconciliations, R&D schedules, grant spend reports, revenue treatment notes, payroll breakdowns, contractor spend, and board reporting packs.
This gives founders a clearer financial story before Seed, Series A, bridge rounds, grant renewals, licensing talks, or acquisition interest.
- Monthly management accounts
- Investor reporting packs
- Data room financial schedules
- R&D and grant summaries
- Board reporting support
- Clean balance sheet review
- Due diligence preparation
Biomedical Bookkeeping and Monthly Close Support
Biomedical startup bookkeeping needs structure from the start. If your chart of accounts is too basic, your R&D, grant, clinical, payroll, contractor, and lab costs become harder to defend later.
We set up bookkeeping systems that give founders cleaner monthly numbers. Transactions are coded by cost type, project, grant, department, research activity, and reporting need. That reduces clean-up work before tax claims, audits, grant reports, and investor requests.
This service is useful for pre-revenue startups, funded research teams, medtech companies, diagnostics firms, digital health companies, and healthcare SaaS businesses.
- Chart of accounts setup
- Monthly transaction coding
- Bank and card reconciliations
- Payroll and contractor cost coding
- Grant and project tracking
- Research spend categories
- Month-end close support
Payroll, Contractor, and Equity Compensation Accounting
Biomedical startups often rely on scientists, clinicians, consultants, contractors, software teams, fractional specialists, and founders taking limited pay before a raise. Poor payroll and contractor tracking can weaken R&D claims, grant reporting, and investor reporting.
We help organise payroll, contractor payments, department coding, project allocation, and founder compensation records. Where equity compensation, options, or stock-based pay affect reporting, we help keep the accounting trail cleaner for review.
This gives your company better cost visibility and clearer records around the people building the product, trial, platform, or research programme.
- Payroll cost allocation
- Contractor payment coding
- Research team cost tracking
- Founder compensation records
- Equity compensation accounting support
- Grant-funded payroll reporting
- Department and project mapping
Audit Readiness and Due Diligence Support
Biomedical startups often wait until a funding round, grant review, audit, acquisition conversation, or investor request before cleaning financial records. That creates pressure at the worst possible time.
We review your accounts before the questions arrive. That means checking reconciliations, revenue treatment, grant cost tracking, R&D schedules, payroll allocation, contractor spend, deferred revenue, supporting documents, and reporting gaps.
The goal is simple: fewer surprises, faster review, and stronger confidence in the financial story behind your company.
- Financial record review
- Audit trail checks
- Due diligence schedule preparation
- Grant documentation review
- R&D support files
- Revenue recognition checks
- Investor question preparation
Place this section after the 8 service blocks and before testimonials/case studies.
Biomedical and healthcare startups often operate across borders. A UK company may raise US capital, work with US research partners, apply for US grants through a related entity, license IP internationally, or report to investors who expect US-style financial controls.
We support finance structures that need clarity across UK and US-facing accounting needs. That includes R&D tax credit preparation, grant cost tracking, ASC 606 revenue support, payroll reporting, investor schedules, and board-ready financial packs.
Founders Need Numbers They Can Defend
Case Study: Financial Clean-Up Before Grant Renewal
A biomedical research startup approached us before a grant renewal deadline. Their accounting system showed total spend, but it did not clearly separate payroll, contractors, lab supplies, clinical costs, indirect costs, and general admin. This made grant reporting harder and created pressure before their next review.
We reworked the chart of accounts, created project codes, reviewed historical spend, separated research costs from operating costs, and prepared clearer monthly reporting. The founder could then review grant usage, runway, and upcoming research commitments without relying on manual spreadsheet fixes.
Review Outcomes
- 7 cost categories rebuilt for cleaner reporting
- 14 months of transactions reviewed and recoded
- Grant spend separated from general company overhead
- Payroll and contractor costs mapped to research activity
- Monthly reporting pack reduced manual review time
- Founder gained clearer cash runway visibility before renewal
Finance Discipline for Research-Led Companies
Biomedical accounting needs more than routine filing. The finance function has to support scientific progress, grant compliance, investor trust, tax credit review, and commercial decision-making.
We help founders move from reactive bookkeeping to controlled financial reporting. That means better cost categories, cleaner monthly close routines, clearer R&D records, better revenue treatment, and stronger reporting packs before high-pressure reviews.
Our accounting approach focuses on:
- Cost classification that separates R&D, clinical, grant, payroll, and admin spend
- Monthly close routines that reduce messy catch-up work
- Grant reporting support with stronger audit trails
- Revenue review for licensing, royalties, and milestone payments
- Investor reporting packs that explain burn rate and runway clearly
- Tax credit support files prepared before filing pressure
- Accounting systems that can support growth beyond pre-revenue stage
Biomedical Finance Pressure in Numbers
- Eligible qualified small businesses may apply up to $500,000 of research credit against payroll tax liabilities, subject to IRS rules and qualification.
- NIH and federal grant reporting requires clear cost separation between direct, indirect, allowable, and unallowable costs.
- ASC 606 can affect how licensing fees, royalties, and milestone payments appear in financial statements.
- Clinical-stage companies often carry long periods of high R&D spend before commercial revenue.
- Investor due diligence commonly reviews burn rate, runway, revenue treatment, payroll, contractor costs, and R&D documentation.
Frequently Asked Questions
Yes. Biomedical startups often deal with R&D tax credits, grant reporting, clinical trial spend, payroll cost allocation, licensing revenue, investor reporting, and audit preparation. Basic bookkeeping usually does not give enough detail for those needs
Yes. We help structure cost tracking around direct costs, indirect costs, allowable spend, unallowable spend, payroll, contractors, lab costs, and project codes so reporting is easier to defend.
Yes. We help organise R&D costs, payroll, contractors, supplies, lab spend, and supporting schedules so your tax credit review has cleaner records behind it. Eligibility depends on the facts of your company and the relevant tax rules.
Yes. Pre-revenue companies often need the most help because cash is limited, R&D spend is high, and investor or grant reporting pressure starts early.
Yes. We support accounting review for licensing fees, royalties, collaboration agreements, deferred revenue, and milestone payments where ASC 606 treatment may affect reporting.
Yes. We can review historical transactions, rebuild cost categories, reconcile accounts, map research spend, separate grant costs, and prepare cleaner monthly reports.
We can support common accounting systems such as Xero, QuickBooks, and other startup finance tools. The right setup depends on entity structure, grant activity, reporting needs, transaction volume, and growth stage.
Yes. We help prepare investor-ready financial packs, burn rate reporting, runway models, R&D schedules, grant cost summaries, revenue notes, and reconciled management accounts before diligence starts.
Yes. We help organise CRO invoices, site payments, investigator costs, patient costs, lab fees, accruals, prepaid expenses, and trial-related supplier spend.
We support UK-based and US-facing companies with accounting organisation, reporting preparation, R&D tax credit support, grant cost tracking, and investor financial packs. Specific filing and tax positions depend on your company structure and should be reviewed before action is taken.
Get Your Biomedical Startup Financials Funding-Ready
The science may win attention, but the numbers decide whether funders, investors, grant reviewers, and board members stay confident.
If your accounts are not ready for R&D tax credit review, grant reporting, clinical trial spend, ASC 606 revenue, payroll allocation, or investor due diligence, fix the structure before the pressure arrives.
Book a consultation and let us review where your biomedical accounting needs tightening.
